Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostate Specific Membrane Antigen”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06353321
What this trial is testing

Non-significant Risk (NSR) Study of [68Ga]-PSMA-11 (Illuccix) as a BgRT BioGuide on RefleXion X1

Who this might be right for
Prostate Cancer
University of Texas Southwestern Medical Center 25
Very early researchUnknownNCT01394042
What this trial is testing

Prostate Cancer Imaging With Radioactive Tracer and Ultrasound Detector Compared to MRI and ProstaScint

Who this might be right for
Prostate Cancer
Radiological Associates of Sacramento Medical Group Inc. 12
Not applicableStudy completedNCT02410577
What this trial is testing

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Who this might be right for
Glioblastoma
Memorial Sloan Kettering Cancer Center 2
Not applicableLooking for participantsNCT05022914
What this trial is testing

PSMA Guided Approach for bIoCHEmical Relapse After Prostatectomy-PSICHE

Who this might be right for
Prostate CancerBiochemical Relapse Fo Malignant Neoplasm of ProstateProstate Adenocarcinoma+1 more
Azienda Ospedaliero-Universitaria Careggi 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT06894511
What this trial is testing

An Open-label Study of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI Versus AAA617 in PSMA Positive First-line mCRPC

Who this might be right for
Metastatic Castration Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 7
Early research (Phase 1)UnknownNCT00005992
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Who this might be right for
Prostate Cancer
Jonsson Comprehensive Cancer Center
Not applicableStudy completedNCT06600399
What this trial is testing

Correlation Between Prostate-specific Membrane Antigen Positron Emission Tomography and Arterial Spin Labeling Perfusion Imaging in Glioblastoma

Who this might be right for
Glioblastoma
Lanzhou University Second Hospital 26
Not applicableUnknownNCT06054789
What this trial is testing

Clinical Study on 68Ga-PSMA-33 for PET/CT Imaging of Prostate Cancer

Who this might be right for
Prostate Cancer
Nanjing First Hospital, Nanjing Medical University 8
Early research (Phase 1)Study completedNCT02552394
What this trial is testing

J591 in Patients With Advanced Prostate Cancer and Unfavorable Circulating Tumor Cell Counts

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT04430192
What this trial is testing

Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomy

Who this might be right for
Prostatic Neoplasms
Peter MacCallum Cancer Centre, Australia 20
Early research (Phase 1)Active Not RecruitingNCT04662580
What this trial is testing

ARX517/JNJ-95298177 as Monotherapy or Combination Therapy in Subjects With Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
Janssen Research & Development, LLC 183
Not applicableStudy completedNCT02699424
What this trial is testing

Prospective Evaluation of 68-Ga-prostate Specific Membrane Antigen (PSMA)-Positron Emission Tomograph (PET) and Early Prostatic Specific Antigen (PSA) Kinetics During Salvage Radiotherapy for Personalizing the Management of Men With Relapse of Prostate Cancer After Radical Prostatectomy

Who this might be right for
Relapsed Prostate Cancer
Lund University Hospital 100
Early research (Phase 1)Ended earlyNCT03792841
What this trial is testing

Safety, Tolerability, Pharmacokinetics, and Efficacy of Acapatamab in Subjects With mCRPC

Who this might be right for
Metastatic Castration-resistant Prostate CancerProstate Cancer
Amgen 212
Testing effectiveness (Phase 2)Looking for participantsNCT04175431
What this trial is testing

Prostate Specific Membrane Antigen (PSMA) or (FACBC) PET/CT Site-Directed Therapy for Treatment of Prostate Cancer, Flu-BLAST-PC Study

Who this might be right for
Prostate Adenocarcinoma
University of Washington 100
Testing effectiveness (Phase 2)Active Not RecruitingNCT03976843
What this trial is testing

Prostate Specific Membrane Antigen (PMSA)-Based PET Imaging of High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 175
Early research (Phase 1)Ended earlyNCT03490838
What this trial is testing

177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancer

Who this might be right for
Prostatic Neoplasm
Advanced Accelerator Applications 27
Testing effectiveness (Phase 2)WithdrawnNCT06881823
What this trial is testing

Study to Assess [177Lu]Lu-PSMA-R2 (AAA602) and [225Ac]Ac-PSMA-R2 (AAA802) in Participants With PSMA-positive HRLPC

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals
Early research (Phase 1)Study completedNCT07101354
What this trial is testing

Research on PSMA-Targeted Intraoperative Fluorescent Imaging Agents

Who this might be right for
Prostate Cancer Patients Undergoing Radical ProstatectomyProstate CA
Haitao Niu, MD 32
Not applicableActive Not RecruitingNCT04030338
What this trial is testing

Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate Cancer

Who this might be right for
Prostate CancerProstate NeoplasmProstate Adenocarcinoma+2 more
Memorial Sloan Kettering Cancer Center 58
Early research (Phase 1)UnknownNCT03780075
What this trial is testing

Lu177-EB-PSMA617 Radionuclide Treatment in Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Peking Union Medical College Hospital 50
Next Page